HILLHOUSE INVESTMENT MANAGEMENT, LTD. — SEC Form 4 filings

SEC reporting owner CIK 1510589. 3 Form 4 filings on record with FilingPulse; latest filed 2026-02-03.

Transaction summary — filings shown

Covers all 3 filings on record, filed 2024-02-01 to 2026-02-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
BeiGene, Ltd. (BGNE)10% owner11 leg · 17,842,500 sh · $3,568,500,000
ArriVent BioPharma, Inc. (AVBP)10% owner21 leg · 555,555 sh · $9,999,9901 leg · 555,555 sh · $12,983,3204

Form 4 filings — HILLHOUSE INVESTMENT MANAGEMENT, LTD.

FiledFormIssuerReported transactionsSource
2026-02-034ArriVent BioPharma, Inc. (AVBP)
jointly with HHLR ADVISORS, LTD.
Sale (S): 555,555 @ $23.37EDGAR
2024-12-044BeiGene, Ltd. (BGNE)
jointly with HHLR ADVISORS, LTD.
Sale (S): 17,842,500 @ $200EDGAR
2024-02-014ArriVent Biopharma, Inc. (AVBP)
jointly with HHLR ADVISORS, LTD.
Conversion (C): 3,616,041 · Conversion (C): 313,076 · Purchase (P): 555,555 @ $18 · Conversion (C): 55,000,000 (derivative) @ $0 · Conversion (C): 4,761,903 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1510589 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →